There is no known cure for psoriasis, but treatment to help manage symptoms is available. This includes over-the-counter and prescription-strength creams. For many people with mild psoriasis ...

Less than a quarter of patients diagnosed with mild psoriasis had a body surface area of less than 3% at the time of diagnosis.

The AAD/NPF guidelines define mild psoriasis as <3% BSA and moderate ... often come into play when deciding how to start psoriasis treatment. "I usually start with topical steroids," he said.

SFA Therapeutics, Inc. has announced encouraging results from its Phase 1b clinical trial of SFA-002, an oral drug candidate aimed at treating mild-to-moderate psoriasis. The study demonstrated both ...

Skin and joint pain are common symptoms of generalized pustular psoriasis (GPP ... consider talking with a doctor about the following treatments that may help manage it. You should also contact ...

Spain-based drugmaker REIG JOFRE has signed a commercial agreement with LEO Pharma, a privately-held Danish firm specializing ...

Tapinarof cream was approved in May 2022 for treatment of mild, moderate, or severe plaque psoriasis in adults. As per the pivotal PSOARING trials, “about 40% of patients on tapinarof will ...

Under the NPF classification, psoriasis is considered mild when lesions cover less than 2% of the body surface area (typically on the knees, elbows, scalp, hands, and feet). Topical treatments ...

Turkey: A decade-long study from a tertiary care hospital highlights the effectiveness and safety of narrow-band ultraviolet ...

"Our tailored approach to immune regulation holds promise in providing a safer, more efficacious oral treatment for patients suffering from psoriasis." "Mild-to-moderate patients represent over 80 ...

All treatment emergent adverse events (TEAEs) and treatment-related adverse events (TRAEs) and were mild or moderate. Psoriasis is a chronic, recurrent, inflammatory, and immune-mediated systemic ...